Inventor
GUILLONNEAU CAROLE
FR11 patents
⚠️ This page may combine multiple inventors who share the name “GUILLONNEAU CAROLE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INST NAT SANTE RECH MED
10 patentsUS11090362B2Aug 17, 2021
Pharmaceutical composition comprising IL-34 and a mTOR inhibitor
INST NAT SANTE RECH MED2 citations67
US12466866B2Nov 11, 2025
Mutated interleukin-34 (IL-34) polypeptides and uses thereof in therapy
INST NAT SANTE RECH MED0 citations58
US12146159B2Nov 19, 2024
Methods for obtaining regulatory t cells and uses thereof
INST NAT SANTE RECH MED0 citations56
US12083163B2Sep 10, 2024
Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases
INST NAT SANTE RECH MED0 citations56
US12168694B2Dec 17, 2024
Anti-human CD45RC antibodies and uses thereof
INST NAT SANTE RECH MED0 citations49
US10724001B2Jul 28, 2020
Methods for obtaining regulatory T cells and uses thereof
INST NAT SANTE RECH MED0 citations46
US10591465B2Mar 17, 2020
Methods and kits for labeling, detection and isolation of Foxp3+ regulatory T cells, isolated population of Foxp3+ regulatory T cells thus obtained and uses thereof
INST NAT SANTE RECH MED0 citations46
US10137181B2Nov 27, 2018
Isolated donor MHC-derived peptide and uses thereof
INST NAT SANTE RECH MED1 citations45
US10105425B2Oct 23, 2018
Isolated donor MHC-derived peptide and uses thereof
INST NAT SANTE RECH MED1 citations45
US10155025B2Dec 18, 2018
Method for inhibiting or reducing transplant rejection by adminstration of interleukin-34
INST NAT SANTE RECH MED0 citations43